Spruce Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-27.5M | $-27.6M | $74.0K | $755.0K |
| FY2021 | $-35.9M | $-36.0M | $93.0K | $4.0M |
| FY2022 | $-41.7M | $-41.7M | $8.0K | $3.6M |
| FY2023 | $-33.3M | $-33.3M | $7.0K | $4.6M |
| FY2024 | $-56.0M | $-56.0M | $0 | $5.3M |